Abbott Laboratories financial statements, FY2007–FY2025
Abbott Laboratories reported revenue of $44.3B and net income of $6.52B for the fiscal year ended 2025-12-31, as stated in its filing with US SEC EDGAR. Listed as ABT (NYSE). Fiscal year ends 31 December.
FactReportedAnnual figures as reported, in USD, 5 measures over 19 fiscal years. Each value links to the filing it came from. Nothing is restated, annualised, converted or estimated; a period a filing did not state is shown as a gap.
Annual results by fiscal year
| Fiscal year end | Revenue | Operating income | Net income | Total assets | Stockholders' equity |
|---|---|---|---|---|---|
| 2025-12-31 | $44.3B | $8.05B | $6.52B | $86.7B | $52.1B |
| 2024-12-31 | $42B | $6.83B | $13.4B | $81.4B | $47.7B |
| 2023-12-31 | $40.1B | $6.48B | $5.72B | $73.2B | $38.6B |
| 2022-12-31 | $43.7B | $8.36B | $6.93B | $74.4B | $36.7B |
| 2021-12-31 | $43.1B | $8.43B | $7.07B | $75.2B | $35.8B |
| 2020-12-31 | $34.6B | $5.36B | $4.5B | $72.5B | $32.8B |
| 2019-12-31 | $31.9B | $4.53B | $3.69B | $67.9B | $31.1B |
| 2018-12-31 | $30.6B | $3.65B | $2.37B | $67.2B | $30.5B |
| 2017-12-31 | $27.4B | $1.56B | $477M | $76.3B | $30.9B |
| 2016-12-31 | $20.9B | $3.03B | $1.4B | $52.7B | $20.5B |
| 2015-12-31 | $20.4B | $2.87B | $4.42B | $41.2B | $21.2B |
| 2014-12-31 | $20.2B | $2.6B | $2.28B | $41.2B | $21.5B |
| 2013-12-31 | $19.7B | $2.13B | $2.58B | $42.9B | $25.2B |
| 2012-12-31 | $19.1B | $1.36B | $5.96B | $67.2B | $26.7B |
| 2011-12-31 | $21.4B | $1.63B | $4.73B | $60.3B | $24.4B |
| 2010-12-31 | $35.2B | $6.09B | — | $60.6B | $22.7B |
| 2009-12-31 | $30.8B | $6.24B | — | $52.6B | $23.1B |
| 2008-12-31 | $29.5B | $5.69B | — | $42.4B | $17.5B |
| 2007-12-31 | $25.9B | $4.58B | — | $39.7B | $17.8B |
About these figures
Every number on this page is a fact with a filing behind it, retrieved from US SEC EDGAR and stored with the period it belongs to. Figures are shown as the company reported them for that period; a later restatement supersedes the earlier value rather than overwriting it. Market capitalisation is not shown anywhere on this site because no licensed price source is used; the profile shows reported public float where a filing states it.